Hawryluk P. Kent
SEC insider (Form 3/4/5 filer). CIK 0001673991. President & CEO at MBX Biosciences, Inc. (MBX). 11 reported Form 4/5 transactions since Sep 2024; latest on May 6, 2026. Located in CARMEL, IN.
Companies Hawryluk P. Kent has filed insider reports for
- MBX Biosciences, Inc. (MBX): Director, Officer, President & CEO
Hawryluk P. Kent
CIK: 0001673991
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MBX Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- May 6, 2026MBX
MBX Biosciences, Inc.
SaleDirect607 shares at avg. $29.54$18K - Mar 13, 2026MBX
MBX Biosciences, Inc.
PurchaseIndirect18.5K shares at avg. $28.41$526K - Feb 26, 2026MBX
MBX Biosciences, Inc.
ExerciseDirect28.8K shares at avg. $16.00$460K - Feb 2, 2026MBX
MBX Biosciences, Inc.
AwardDirect35.3K shares- - Oct 24, 2025MBX
MBX Biosciences, Inc.
ExerciseDirect182.9K shares at avg. $3.25$594K - Oct 20, 2025MBX
MBX Biosciences, Inc.
PurchaseIndirect20K shares at avg. $13.64$273K - Feb 4, 2025MBX
MBX Biosciences, Inc.
PurchaseIndirect50K shares at avg. $10.69$535K - Feb 3, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
243K shares- - Sep 16, 2024MBX
MBX Biosciences, Inc.
ConversionIndirect115.9K shares- - Sep 16, 2024MBX
MBX Biosciences, Inc.
ConversionDirect283.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 6, 2026 | MBX MBX Biosciences, Inc. | Sale | 607 | $29.54 | $17,931 | Direct |
| Mar 13, 2026 | MBX MBX Biosciences, Inc. | Purchase | 18,500 | $28.41 | $525,663 | Indirect |
| Feb 26, 2026 | MBX MBX Biosciences, Inc. | Exercise | 28,768 | $16.00 | $460,288 | Direct |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | Award | 35,250 | - | $0 | Direct |
| Oct 24, 2025 | MBX MBX Biosciences, Inc. | Exercise | 182,859 | $3.25 | $594,292 | Direct |
| Oct 20, 2025 | MBX MBX Biosciences, Inc. | Purchase | 20,000 | $13.64 | $272,790 | Indirect |
| Feb 4, 2025 | MBX MBX Biosciences, Inc. | Purchase | 50,000 | $10.69 | $534,500 | Indirect |
| Feb 3, 2025 | MBX MBX Biosciences, Inc. | Award Stock Option (Right to Buy) | 243,000 | - | - | Direct |
| Sep 16, 2024 | MBX MBX Biosciences, Inc. | Conversion | 115,914 | - | $0 | Indirect |
| Sep 16, 2024 | MBX MBX Biosciences, Inc. | Conversion | 283,846 | - | $0 | Direct |
1-10 of 11 transactions